- Home
- ITGR vs VKTX Comparison
ITGR vs VKTX Comparison
Compare ITGR & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITGR | VKTX |
|---|---|---|
| Founded | 1970 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.0B |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ITGR | VKTX |
|---|---|---|
| Price | $126.44 | $30.79 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 20 |
| Target Price | ★ $121.80 | $94.82 |
| AVG Volume (30 Days) | 704.2K | ★ 6.2M |
| Earning Date | 10-22-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.17 | N/A |
| Revenue | ★ $1,853,637,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.96 | N/A |
| P/E Ratio | $108.03 | ★ N/A |
| Revenue Growth | ★ 7.98 | N/A |
| 52 Week Low | $62.00 | $25.77 |
| 52 Week High | $126.80 | $43.15 |
Technical Indicators
Market Signals| Indicator | ITGR | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 73.58 | 47.15 |
| Support Level | $126.16 | $29.52 |
| Resistance Level | $126.54 | $35.47 |
| Average True Range (ATR) | 0.18 | 2.30 |
| MACD | -0.44 | -0.06 |
| Stochastic Oscillator | 63.64 | 27.41 |
Price Performance
Historical ComparisonAbout ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.